有关多发性硬化症（MS）患者 COVID-19 大流行的知识：来自伊朗的报告。
Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran.
机构信息
Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Mult Scler Relat Disord. 2020 Jul;42:102193. doi: 10.1016/j.msard.2020.102193. Epub 2020 May 14.
Abstract
• 90% of MS patients knew that COVID-19 is in a pandemic stage. • 73% followed quarantine guidelines completely. • All participants believed high person-to-person transmission rate of COVID-19.
摘要
• 90%的多发性硬化症患者知道 COVID-19 处于大流行阶段。
• 73%的患者完全遵守了隔离准则。
• 所有参与者都认为 COVID-19 的人际传播率很高。
相似文献
1
Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran.有关多发性硬化症（MS）患者 COVID-19 大流行的知识：来自伊朗的报告。
Mult Scler Relat Disord. 2020 Jul;42:102193. doi: 10.1016/j.msard.2020.102193. Epub 2020 May 14.
2
Epidemic curve and reproduction number of COVID-19 in Iran.伊朗新冠肺炎疫情曲线及再生数
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa077.
3
Nowruz travelers and the COVID-19 pandemic in Iran.伊朗的诺鲁孜节旅行者与新冠疫情
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1121. doi: 10.1017/ice.2020.152. Epub 2020 Apr 20.
4
SARS-CoV-2 Pandemic: Should Children Wear Masks?新型冠状病毒肺炎大流行：儿童应该戴口罩吗？
Acta Med Port. 2020 Oct 1;33(10):711. doi: 10.20344/amp.14787. Epub 2020 Sep 3.
5
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
6
Iran's success in controlling the COVID-19 pandemic.伊朗在控制新冠疫情方面的成功。
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1359-1360. doi: 10.1017/ice.2020.169. Epub 2020 Apr 23.
7
Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.划分曲线——新冠疫情期间的州际旅行限制
N Engl J Med. 2020 Sep 24;383(13):e83. doi: 10.1056/NEJMp2024274. Epub 2020 Aug 5.
8
Centralized medical quarantine for imported COVID-19 in Shanghai, China.中国上海对输入性新冠肺炎病例进行集中医学隔离。
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa109.
9
Novel coronavirus, poor quarantine, and the risk of pandemic.新型冠状病毒、隔离措施不力与大流行风险。
J Hosp Infect. 2020 Apr;104(4):449-450. doi: 10.1016/j.jhin.2020.02.002. Epub 2020 Feb 11.
10
Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems.伊朗2019冠状病毒病（COVID-19）疫情：行动与问题
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755. doi: 10.1017/ice.2020.86.
引用本文的文献
1
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey.多发性硬化症患者对新冠疫苗的态度评估、其与人口统计学因素的相关性以及对冠状病毒的恐惧：一项横断面调查。
Curr J Neurol. 2022 Oct 7;21(4):230-235. doi: 10.18502/cjn.v21i4.11720.
2
Multiple sclerosis and COVID-19: A retrospective study in Iran.多发性硬化症和 COVID-19：伊朗的回顾性研究。
PLoS One. 2023 Mar 23;18(3):e0283538. doi: 10.1371/journal.pone.0283538. eCollection 2023.
3
Assessment of Multiple Sclerosis Patients' Knowledge and Behavioral Practice Regarding COVID-19 in Saudi Arabia.沙特阿拉伯多发性硬化症患者对2019冠状病毒病的知识与行为实践评估
Cureus. 2022 Dec 21;14(12):e32781. doi: 10.7759/cureus.32781. eCollection 2022 Dec.
4
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS).多发性硬化症（MS）患者在大流行阶段感染新冠病毒的预测因素。
Int J Prev Med. 2022 Jul 15;13:102. doi: 10.4103/ijpvm.IJPVM_480_20. eCollection 2022.
5
Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis.多发性硬化症患者对 COVID-19 症状、风险因素和疫苗接种的认知。
Int J Environ Res Public Health. 2022 Mar 12;19(6):3366. doi: 10.3390/ijerph19063366.
6
COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021.2021 年 5 月伊朗多发性硬化症患者 COVID-19 感染和住院率：我们所了解的情况。
Mult Scler Relat Disord. 2022 Jan;57:103335. doi: 10.1016/j.msard.2021.103335. Epub 2021 Oct 16.
7
Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.多发性硬化症患者对 COVID-19 大流行和疫苗的意见、信念和知识。
Mult Scler Relat Disord. 2021 Sep;54:103113. doi: 10.1016/j.msard.2021.103113. Epub 2021 Jun 26.
8
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.COVID-19 感染在多发性硬化症（MS）患者中的流行情况：系统评价和荟萃分析。
Neurol Sci. 2021 Aug;42(8):3093-3099. doi: 10.1007/s10072-021-05373-1. Epub 2021 Jun 7.
9
Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?脉冲类固醇疗法会增加多发性硬化症患者感染 COVID-19 的风险吗？
Clin Neurol Neurosurg. 2021 Apr;203:106563. doi: 10.1016/j.clineuro.2021.106563. Epub 2021 Feb 15.
10
Ethical considerations in neurology during the COVID-19 pandemic.COVID-19 大流行期间神经病学中的伦理问题。
Neurol Sci. 2021 Feb;42(2):437-444. doi: 10.1007/s10072-020-05032-x. Epub 2021 Jan 2.
本文引用的文献
1
Erratum to ``A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence'' [International Journal of Antimicrobial Agents 55/6 (2020) 105948].《基于当前证据对2019新型冠状病毒（COVID-19）的综述》勘误 [《国际抗菌剂杂志》55/6（2020）105948]
Int J Antimicrob Agents. 2020 Sep;56(3):106137. doi: 10.1016/j.ijantimicag.2020.106137. Epub 2020 Aug 18.
2
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.2019 年冠状病毒病（COVID-19）的全球流行病学：疾病发病率、每日累计指数、死亡率，及其与国家医疗资源和经济状况的关系。
Int J Antimicrob Agents. 2020 Apr;55(4):105946. doi: 10.1016/j.ijantimicag.2020.105946. Epub 2020 Mar 19.
3
COVID-19 battle during the toughest sanctions against Iran.在对伊朗最严厉制裁期间的新冠疫情防控战。
Lancet. 2020 Mar 28;395(10229):1035-1036. doi: 10.1016/S0140-6736(20)30668-1. Epub 2020 Mar 18.
4
Effects of Vitamin D Supplements on IL-10 and INFγ Levels in Patients with Multiple Sclerosis: a Systematic Review and Meta-Analysis.维生素D补充剂对多发性硬化症患者白细胞介素-10和干扰素γ水平的影响：一项系统评价和荟萃分析。
Maedica (Bucur). 2019 Dec;14(4):413-417. doi: 10.26574/maedica.2019.14.4.413.
5
The Outbreak Cases with the Novel Coronavirus Suggest Upgraded Quarantine and Isolation in Korea.韩国出现的新型冠状病毒疫情病例表明需加强隔离措施。
J Korean Med Sci. 2020 Feb 10;35(5):e62. doi: 10.3346/jkms.2020.35.e62.
6
Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis.那他珠单抗治疗多发性硬化症（MS）患者的血清转换和血清学逆转发生率：系统评价和荟萃分析。
J Clin Neurosci. 2020 Jan;71:129-134. doi: 10.1016/j.jocn.2019.08.103. Epub 2019 Sep 23.
7
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study.多发性硬化症的疾病修正药物与感染风险：一项队列研究。
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1050-1056. doi: 10.1136/jnnp-2017-317493. Epub 2018 Mar 30.
8
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.抑郁症状与多发性硬化症患者的残疾及病程相关：一项使用贝克抑郁量表的意大利多中心研究
PLoS One. 2016 Sep 15;11(9):e0160261. doi: 10.1371/journal.pone.0160261. eCollection 2016.
9
Epidemiology and control of SARS in Singapore.新加坡严重急性呼吸综合征的流行病学与防控
Ann Acad Med Singap. 2006 May;35(5):301-16.
Zotero 插件